SCHEMBL4943798

SCHEMBL4943798

N=C(N)NC(=O)c1ccc(-c2cccc(Cl)c2)o1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 1/20 0.61
S1PR4 O95977 1/20 0.60
ALDH1A1 P00352 5/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
MAPT P10636 4/20 0.56
KDM4E B2RXH2 3/20 0.56
RAB9A P51151 2/20 0.56
NPC1 O15118 2/20 0.56
LMNA P02545 1/20 0.56
HPGD P15428 3/20 0.55
GAA P10253 2/20 0.55
MGAM O43451 1/20 0.55
SI P14410 1/20 0.55
MGAM2 Q2M2H8 1/20 0.55
C3AR1 Q16581 1/20 0.53
SAE1 Q9UBE0 2/20 0.52
UBA2 Q9UBT2 2/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
MAPK1 P28482 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4943398 0.88 SLC9A1 (0.58) SLC9A1S1PR4ALDH1A1SMN1; SMN2MAPT
SCHEMBL4936895 0.85 ALDH1A1 (0.50) SLC9A1S1PR4ALDH1A1SMN1; SMN2MAPT
SCHEMBL4936806 0.84 SLC9A1 (0.61) SLC9A1S1PR4ALDH1A1MAPTKDM4E
SCHEMBL4937176 0.82 SLC9A1 (0.59) SLC9A1S1PR4ALDH1A1SMN1; SMN2MAPT
SCHEMBL27585207 0.82 SLC9A1 (0.72) SLC9A1S1PR4ALDH1A1SMN1; SMN2MAPT
SCHEMBL4941158 0.80 ALDH1A1 (0.74) ALDH1A1SMN1; SMN2MAPTKDM4ERAB9A
SCHEMBL4944299 0.80 S1PR4 (0.51) SLC9A1S1PR4ALDH1A1SMN1; SMN2MAPT
SCHEMBL4946319 0.79 SLC9A1 (0.61) SLC9A1S1PR4ALDH1A1MAPTKDM4E
SCHEMBL4944695 0.79 CYP1A2 (0.62) SLC9A1ALDH1A1SMN1; SMN2KDM4EHPGD
SCHEMBL3719608 0.78 SLC9A1 (0.59) SLC9A1S1PR4ALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351843-B2 Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-04-01 US disclosed
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them SLC9A1, NHERF1, SLC5A1 SLC9A1 1/4885S1PR4 2223/4885ALDH1A1 297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.